Victory Capital Management
IRON icon

Victory Capital Management’s Disc Medicine IRON Stock Holding History

Victory Capital Management’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.13M Sell
29,117
-101
-0.3% -$6.94K ﹤0.01% 1606
2026
Q1 		$1.87M Sell
29,218
-47,120
-62% -$3.27M ﹤0.01% 1617
2025
Q4 		$6.06M Sell
76,338
-73,526
-49% -$6.21M ﹤0.01% 1243
2025
Q3 		$9.9M Sell
149,864
-47,960
-24% -$2.85M 0.01% 1112
2025
Q2 		$10.5M Buy
197,824
+4,160
+2% +$195K 0.01% 1098
2025
Q1 		$9.61M Sell
193,664
-42,580
-18% -$2.37M 0.01% 1064
2024
Q4 		$15M Buy
236,244
+16,230
+7% +$939K 0.01% 944
2024
Q3 		$10.8M Sell
220,014
-92,035
-29% -$4.32M 0.01% 1082
2024
Q2 		$14.1M Buy
312,049
+98,988
+46% +$3.36M 0.01% 944
2024
Q1 		$13.3M Buy
213,061
+25,481
+14% +$1.65M 0.01% 963
2023
Q4 		$10.8M Buy
187,580
+50,057
+36% +$2.56M 0.01% 1025
2023
Q3 		$6.46M Buy
+137,523
New +$6.88M 0.01% 1158

Other funds holding IRON

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Victory Capital Management's IRON Position: Q2 2026 in Review

Victory Capital Management reduced its Disc Medicine (IRON) stake by 0.35% in Q2 2026, selling an estimated $6.94K and leaving 29,117 shares worth $2.13M. The position accounts for ﹤0.01% of the portfolio, ranked #1606.

Victory Capital Management first reported a position in IRON in Q3 2023 and has held it in 12 quarters since. The position peaked at $15M in Q4 2024. 216 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

  • Victory Capital Management held 29,117 shares of Disc Medicine worth $2.13M as of Q2 2026.
  • Victory Capital Management sold 101 Disc Medicine shares in Q2 2026, an estimated $6.94K.
  • Disc Medicine made up ﹤0.01% of Victory Capital Management's portfolio in Q2 2026, its #1606 holding.
  • Victory Capital Management first reported a position in Disc Medicine in Q3 2023 and has held it in 12 quarters since.
  • Victory Capital Management's Disc Medicine position peaked at $15M in Q4 2024.
  • 216 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on Victory Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.